ZANTE GREG (Chief Financial Officer) received a stock award from VIKING THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/30/2021ACC: 0001209191-21-058246
Officer· Chief Financial Officer
Since Jan 2021
+4.36K
Net shares
Net buyer
$15.0K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
6.67K acquired · 2.31K disposed
Non-Derivative Transactions2
Common Stock, par value $0.00001 per share
Direct
Shares
+6.67K
Price / share
—
Trade value
—
% of position
7.4%
9/28/2021
90.12K→96.79K
Common Stock, par value $0.00001 per share
Direct
Shares
−2.31K
Price / share
$6.50
Trade value
$14.99K
% of position
2.4%
9/28/2021
96.79K→94.48K
Total
Net shares
+4.36K
Net value
-$14.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 9/28/2021 | A · Award | +6.67K | — | — | 7.4% | 90.12K | 96.79K |
| Common Stock, par value $0.00001 per share Direct | 9/28/2021 | F · Tax Withholding | −2.31K | $6.50 | $14.99K | 2.4% | 96.79K | 94.48K |
| Total | +4.36K | -$14.99K | ||||||
Derivative Transactions0
No derivative transactions reported